Second malignancies after radiation treatment and chemotherapy for primary cancers Chapter uri icon

Overview

MeSH Major

  • Carcinoma
  • Heart Neoplasms
  • Melanoma
  • Neoplasms
  • Sarcoma

abstract

  • Cancer survivors have been shown to have an increased risk for second malignant neoplasms (SMN). These increased risks result from genetic predisposition, harmful environmental exposures, or cancer treatment therapies. Regardless of their cause, SMNs now comprise the sixth most common group of malignancies after skin, prostate, breast, lung, and colorectal cancers.1 It is important to emphasize that the fear of SMN related to the treatment of the first cancer diagnosis should not outweigh the positive effects of curative therapy for the first cancer. Both physicians and patients should, however, be aware of the consequences of the cancer treatment regimens, specifically radiation therapy (RT) and chemotherapy, and consider them while devising follow-up plans. © 2007 Springer Science+Business Media, LLC.

publication date

  • December 2007

Research

keywords

  • Book Chapter

Identity

Digital Object Identifier (DOI)

  • 10.1007/978-0-387-68265-5_17

Additional Document Info

start page

  • 225

end page

  • 237